All Stories

  1. Development and validation of a rapid stability indicating HPLC-method using monolithic stationary phase and two spectrophotometric methods for determination of antihistaminic acrivastine in capsules
  2. Multifactorial design principles applied for the simultaneous separation of local anesthetics using chromatography modeling software
  3. Chromatography Modeling Software Applicability for Non-Conventional Columns: a Case Study of Calixarene- and Resorcinarene-Bonded Stationary Phases
  4. Evaluation of (S)- and (R)-Misonidazole as GPX Inhibitors: Synthesis, Characterization Including Circular Dichroism andIn VitroTesting on Bovine GPx-1
  5. Intergroup cross-comparison for the evaluation of data-interchangeability from various chromatographic tests
  6. Isolation of farnesylhydroquinones from the basidiomycete Ganoderma pfeifferi
  7. Analytical power of LLE–HPLC–PDA–MS/MS in drug metabolism studies: Identification of new nabumetone metabolites
  8. Evaluation of the Chromatographic Performance of Conventional, Polar-Endcapped and Calixarene-Bonded Stationary Phases for the Separation of Water-Soluble Vitamins
  9. Complexation of Achiral Calixarenes with Chiral Pharmaceutical Substances: A Circular Dichroism Study
  10. Complexation of Achiral Calixarenes with Chiral Pharmaceutical Substances: A Circular Dichroism Study
  11. Spectrophotometric and Stability–Indicating High–Performance Liquid Chromatographic Determinations of Terbutaline Sulfate
  12. Improvement of Separation in Non-Aqueous Capillary Electrophoresis using Surfactants and Calixarenes as Additives
  13. Effect of chromatographic conditions on liquid chromatographic chiral separation of terbutaline and salbutamol on Chirobiotic V column
  14. Selectivity of calixarene-bonded silica phases in HPLC: Description of special characteristics with a multiple term linear equation at different methanol concentrations
  15. Flüssigehromatographische Trennung von Anthracen und seinen Hydrierprodukten
  16. Characterization of calixarene-bonded stationary phases
  17. Chromatographic Application on Calixarene Bonded Stationary Phases: A Stability Indicating LC-Method for Determination of Celecoxib in Tablet Formulation
  18. Description of retention characteristics of calixarene-bonded stationary phases in dependence of the methanol content in the mobile phase
  19. Selectivity of Calixarene-bonded Silica-phases in HPLC: Description of Special Characteristics with a Multiple Term Linear Equation at Two Different pH-Values
  20. Comparison of the Chromatographic Behavior of Tricyclic Neuroleptics on Calixarene-Bonded, Monolithic and Conventional RP-HPLC Columns
  21. Achiral and chiral high-performance liquid chromatographic determination of flubendazole and its metabolites in biomatrices using UV photodiode-array and mass spectrometric detection
  22. Calixarene HPLC Phases - Applications
  23. Effect of chaotropic mobile phase additives on retention behaviour of beta-blockers on various reversed-phase high-performance liquid chromatography columns
  24. Retention behaviour of beta-blockers in HPLC using a monolithic column
  25. Peak shape improvement of basic analytes in capillary liquid chromatography
  26. Evaluation of packed capillary liquid chromatography columns and comparison with conventional-size columns
  27. Characterization of calixarene- and resorcinarene-bonded stationary phases
  28. Extracolumn band broadening in capillary liquid chromatography
  29. Investigation of the retention behaviour of steroids with calixarene-based stationary phases by modern NMR spectroscopy
  30. Separation of (Z)- and (E)-isomers of thioxanthene and dibenz[b,e]oxepin derivatives with calixarenes and resorcinarenes as additives in nonaqueous capillary electrophoresis
  31. Separation of cis- and trans-isomers of thioxanthene and dibenz[b,e]oxepin derivatives on calixarene- and resorcinarene-bonded high-performance liquid chromatography stationary phases
  32. Chiral separation of amino acid esters by micellar electrokinetic chromatography
  33. Chiral separations of 1,3,4-thia- and 1,3,4-selenadiazine derivatives by use of non-aqueous capillary electrophoresis
  34. New calixarene-bonded stationary phases in high-performance liquid chromatography: comparative studies on the retention behavior and on influences of the eluent
  35. Chiral separation of unmodified amino acids with non-aqueous capillary electrophoresis based on the ligand-exchange principle
  36. Nonaqueous capillary electrophoresis: Application possibilities and suitability of various solvents for the separation of basic analytes
  37. Nonaqueous capillary electrophoresis: Application possibilities and suitability of various solvents for the separation of basic analytes
  38. Use of cationic cyclodextrin for enantioseparation by capillary electrophoresis
  39. Use of chiral and achiral ion-pairing reagents in combination with cyclodextrins in capillary electrophoresis
  40. Circular dichroism of axially chiral methaqualone, 3-Aryl-2-mercapto- and 3-aryl-2-alkylthio-4(3H)-quinazolinones: conformational dependence of CD and assignment of absolute configuration
  41. Circular dichroism of axially chiral methaqualone, 3‐Aryl‐2‐mercapto‐ and 3‐aryl‐2‐alkylthio‐4(3H)‐quinazolinones: conformational dependence of CD and assignment of absolute configuration
  42. Capillary electrophoretic chiral resolution of vicinal diols by complexation with borate and cyclodextrin: Comparative studies on different cyclodextrin derivatives
  43. Highlight
  44. Influence of different types of cyclodextrins on the racemization of scopolamine-N-butylbromide
  45. Enantioselective influence of cyclodextrins on cleavage of chiralic esters
  46. Zur HPLC-Trennung einiger Mandelsäureesterderivate mittels α1-Glykoprotein (AGP)
  47. Alterations of purine metabolism in mononuclear cell populations of first degree relatives of insulin-dependent diabetic individuals with disturbed glucose tolerance
  48. Alterations of purine metabolism in mononuclear cells of individuals at risk of developing type I (insulin-dependent) diabetes mellitus
  49. Zur Stabilität von Allopurinol und lyophilisiertem Allopurinol- Natrium